2 01/04/2025 31/03/2026 2026-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2025-04-01 Sage Accounts Production 25.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 5641183 2025-04-01 2026-03-31 5641183 2026-03-31 5641183 2025-03-31 5641183 2024-04-01 2025-03-31 5641183 2025-03-31 5641183 2024-03-31 5641183 bus:Director1 2025-04-01 2026-03-31 5641183 core:WithinOneYear 2026-03-31 5641183 core:WithinOneYear 2025-03-31 5641183 bus:Director1 2025-03-31 5641183 bus:Director1 2026-03-31 5641183 bus:Director1 2024-03-31 5641183 bus:Director1 2025-03-31 5641183 bus:Director1 2024-04-01 2025-03-31 5641183 bus:Micro-entities 2025-04-01 2026-03-31 5641183 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 5641183 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 5641183 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 5641183 bus:FullAccounts 2025-04-01 2026-03-31
Company registration number: 5641183
WESSEX PHARMA SERVICES LTD
Unaudited filleted financial statements
31 March 2026
WESSEX PHARMA SERVICES LTD
Statement of financial position
31 March 2026
2026 2025
£ £
Fixed assets - 980
_______ _______
Current assets 22,809 64,089
Creditors: amounts falling due within one year ( 1,134) ( 2,670)
_______ _______
Net current assets 21,675 61,419
_______ _______
Total assets less current liabilities 21,675 62,399
Accruals and deferred income ( 1,025) ( 1,025)
_______ _______
Net assets 20,650 61,374
_______ _______
Capital and reserves 20,650 61,374
_______ _______
Notes to the financial statements
WESSEX PHARMA SERVICES LTD
Year ended 31 March 2026
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2025: 2 ).
2. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2026
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
Andrew Hadlington ( 1,297) ( 186) 460 ( 1,023)
_______ _______ _______ _______
2025
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
Andrew Hadlington ( 50) ( 1,247) - ( 1,297)
_______ _______ _______ _______
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 12 May 2026 , and are signed on behalf of the board by:
Andrew Hadlington
Director
Company registration number: 5641183
The company is a private company limited by shares, registered in England and Wales.